Physician profile
Chris R Siemens
NPI 1972598241
$2,375.69
in general payments reported to CMS, 2019-2025
17 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $113 · 2021: $118 · 2022: $403 · 2023: $378 · 2024: $475 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $617.54 | 2019-2025 | Dupixent |
| Genzyme Corporation | $450.80 | 2019-2025 | |
| Stryker Corporation | $277.03 | 2019-2020 | |
| Livanova USA, INC. | $235.11 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Optinose US, INC. | $175.53 | 2019-2025 | |
| Glaxosmithkline, LLC. | $169.95 | 2022-2025 | Nucala |
| Medtronic, INC. | $154.93 | 2021-2024 | Quadcut |
| Sanofi-Aventis U.S. LLC | $87.12 | 2022 | |
| Alk-Abello, INC | $48.68 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Cochlear Americas | $33.05 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Inspire Medical Systems, INC. | $24.32 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $20.88 | 2019 | |
| Microtransponder, INC. | $18.97 | 2024 | |
| Integra Lifesciences Corporation | $17.26 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Hologic Sales and Service, LLC | $15.67 | 2023 | Coolseal Generator |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $14.71 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.14 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Siemens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.